Integrating complete lower limb venous ultrasound into diagnostic strategies for pulmonary embolism: a cost-effectiveness analysis

• References

• 1 Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). The PIOPED Investigators. JAMA 1990; 263: 2753-9.
• 2 Perrier A, Desmarais S, Miron MJ. et al. Noninvasive diagnosis of venous thromboembolism in outpatients. Lancet 1999; 353: 190-5.
• 3 Wells PS, Anderson DR, Rodger M. et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med 2001; 135: 98-107.
• 4 Musset D, Parent F, Meyer G. et al. Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicentre outcome study. Lancet 2002; 360: 1914-20.
• 5 van Strijen MJ, de Monye W, Schiereck J. et al. Single-detector helical computed tomography as the primary diagnostic test in suspected pulmonary embolism: a multicenter clinical management study of 510 patients. Ann Intern Med 2003; 138: 307-14.
• 6 Oudkerk M, van Beek EJ, van Putten WL. et al. Cost-effectiveness analysis of various strategies in the diagnostic management of pulmonary embolism. Arch Intern Med 1993; 153: 947-54.
• 7 Hull RD, Feldstein W, Stein PD, Pineo GF. Cost-effectiveness of pulmonary embolism diagnosis. Arch Intern Med 1996; 156: 68-72.
• 8 van Erkel AR, van Rossum AB, Bloem JL, Kievit J, Pattynama PM. Spiral CT angiography for suspected pulmonary embolism: a cost-effectiveness analysis. Radiology 1996; 201: 29-36.
• 9 van Erkel AR, Pattynama PM. Cost-effective diagnostic algorithms in pulmonary embolism: an updated analysis. Acad Radiol 1998; 5 Suppl 2: S321-7.
• 10 van Erkel AR, van den Hout WB, Pattynama PM. International differences in health care costs in Europe and the United States: Do these affect the cost-effectiveness of diagnostic strategies for pulmonary embolism?. Eur Radiol 1999; 09: 1926-31.
• 11 Paterson DI, Schwartzman K. Strategies incorporating spiral CT for the diagnosis of acute pulmonary embolism: a cost-effectiveness analysis. Chest 2001; 119: 1791-800.
• 12 Perrier A, Nendaz MR, Sarasin FP, Howarth N, Bounameaux H. Cost-effectiveness analysis of diagnostic strategies for suspected pulmonary embolism including helical computed tomography. Am J Respir Crit Care Med 2003; 167: 39-44.
• 13 Elias A, Colombier D, Victor G, Elias M, Arnaud C, Juchet H. et al. Diagnostic performance of complete lower limb venous ultrasound in patients with clinically suspected acute pulmonary embolism. Thromb Haemost 2004; 91: 187-95.
• 14 Stein PD, Athanasoulis C, Alavi A. et al. Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation 1992; 85: 462-8.
• 15 Perrier A, Bounameaux Ft. Cost-effective diagnosis of deep vein thrombosis and pulmonary embolism. Thromb Haemost 2001; 86: 475-87.
• 16 Mullins MD, Becker DM, Hagspiel KD. et al. The role of spiral volumetric computed tomography in the diagnosis of pulmonary embolism. Arch Intern Med 2000; 160: 293-8.
• 17 Rathbun SW, Raskob GE, Whitsett TL. Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review. Ann Intern Med 2000; 132: 227-32.
• 18 Barritt DWJS. Anticoagulation drugs in the treatment of pulmonary embolism: a controlled trial. Lancet 1960; 01: 1309-12.
• 19 Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975; 17: 259-70.
• 20 Alpert JS, Smith R, Carlson J. et al. Mortality in patients treated for pulmonary embolism. Jama 1976; 236: 1477-80.
• 21 Carson JL, Kelley MA, Duff A. et al. The clinical course of pulmonary embolism. N Engl J Med 1992; 326: 1240-5.
• 22 Giuntini C, Di Ricco G, Marini C. et al. Pulmonary embolism: epidemiology. Chest 1995; 107: 3S-9S.
• 23 Hull RD, Raskob GE, Ginsberg JS. et al. A noninvasive strategy for the treatment of patients with suspected pulmonary embolism. Arch Intern Med 1994; 154: 289-97.
• 24 Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. The Columbus Investigators. N Engl J Med 1997; 337: 657-62.
• 25 Simonneau G, Sors H, Charbonnier B. et al. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l’Embolie Pulmonaire. N Engl J Med 1997; 337: 663-9.
• 26 Douketis JD, Kearon C, Bates S. et al. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998; 279: 458-62.
• 27 Hyers TM, Agnelli G, Hull RD. et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001; 119: 176S-193S.
• 28 Levine MN, Raskob G, Landefeld S. et al. Hemorrhagic complications of anticoagulant treatment. Chest 2001; 119: 108S-121S.
• 29 Hull RD, Pineo GF, Stein P. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring. Int Angiol 1998; 17: 213-24.
• 30 Gould MK, Dembitzer AD, Doyle RL. et al. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med 1999; 130: 800-9.
• 31 Agence Technique Information Hospitalisation. Actualites MCO: Echelle nationale des couts relatifs par GHM, annee 2002. Mission PMSI www.atih.sante.fr/pmsi 2003
• 32 Union des Caisses Nationales de Securite Sociale. Nomenclature Generale des Actes Professionnels, Nomenclature Generale des Actes de Biologie Medicale. Union des Caisses Nationales de Securite Sociale; Paris, 2001: 2001
• 33 Drummond MF Methods for the economic evaluation of health care programmes. 2nd. Oxford; New York: Oxford University Press; 1997